Lung cancer survival rates are up thanks to immunotherapy, other ... - NPR
Apr 12, 2024 · Lung cancer remains the most lethal form of the disease, killing about 135,000 Americans a year – more than breast, prostate and colon cancer combined – which is why many people still think of...
Osimertinib Improves Survival in Lung Cancer - NCI
Jul 5, 2023 · Improved overall survival with osimertinib. The initial results from ADAURA, published in October 2020, offered signs of possible survival improvements with adjuvant osimertinib. This treatment, they showed, dramatically improved how long people lived without any evidence of their cancer returning.
Lung cancer treatment: Pfizer's Lorbrena extends life in ... - NBC News
May 31, 2024 · Pfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for years longer than other drugs, according to new research published Friday. The drug treats a...
After Four Decades, a Breakthrough for Lung Cancer
Learn about just some of our achievements in this Annual Report. When Karen Milich stopped responding to lung cancer treatments, she enrolled in an MSK-led clinical trial testing a drug that targets the KRAS mutation. The drug, sotorasib, was a breakthrough, 40 years in the making.
Lung cancer treatment produces progression-free survival results …
Jun 5, 2024 · The positive results from the LAURA Phase III trial underscore the importance of early testing and diagnosis in lung cancer, which remains the leading cause of cancer death worldwide,...
Lung Cancer News -- ScienceDaily
Oct 1, 2024 · Information about lung cancer symptoms and treatments. Explore the latest medical research on cancers including experimental treatments.
Pfizer lung cancer drug shows promising long-term trial results
May 31, 2024 · CHICAGO — Pfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term results in a late-stage trial, which may help establish it as the new standard treatment...
FDA Approves New Drug for Deadly Lung Cancer - U.S. News
FRIDAY, May, 17, 2024 (HealthDay News) -- The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer.
US lung cancer survival rates rise, but it’s still the leading ... - CNN
Nov 14, 2023 · Over the past five years, the five-year survival rate for lung cancer in the US has increased a significant 22%, according to a new report from the American Lung Association.
Significant Advances in Lung Cancer Treatment Bring Hope
May 5, 2022 · Historically, following diagnosis, patients with early-stage lung cancer had surgery sometimes followed by chemotherapy. A recent FDA-approved treatment that combines chemotherapy and immunotherapy, given before surgery, is bringing new hope.
- Some results have been removed